Over View

Nuwill is a science and innovation driven Research and Development Company providing dosage form development and analytical services to the global pharmaceutical industry. Nuwill’s vision is to be the benchmark in pharmaceutical product development company to develop own innovative dosage form and serving likeminded customers in CRO space. We strive to do this with our mix of broad scientific capabilities, seasoned talent, attentive customer service and an exceptional quality and integrity record. By providing extensive technical capabilities and a high level of customer service, Nuwill continues to grow with new and repeat business. This has resulted in a balanced client base of major multinational and virtual pharmaceutical companies located across the globe both as stand alone business and joint venture developments.

Nuwill's comprehensive offerings include Preformulation studies, dosage form development, analytical services, novel drug delivery systems, preclinical evaluation, proof of concept studies (POC) and stability studies. These services are complemented by full analytical, regulatory, quality and project management support. Nuwill develops a wide range of dosage forms covering solid, semi-solid, liquid and parenteral,transdernal patches, nanotechnology based formulations.We also have associate companies to develop potent molecules like oncology, hormonal and steroidal products. We create customized solutions to help you achieve your development goals, reduce costs and accelerate time-to-market.

Nuwill provides an end to end solution in technology transfers starting from identifying CMOs to monitor technical operation of commercial production for overseas clients as standalone service.Nuwill will take responsibility of technical trouble shooting of formulations all along commercial life span.

Nuwill's highly trained scientific team and highly technical management team, has extensive experience working with a variety of drug substances that have a broad range of physicochemical characteristics. Additionally, Nuwill's development expertise includes immediate, modified and sustained release formulations. Each formulation is designed around the molecule's physicochemical properties and the dosage form desired.

Nuwill's development capabilities are mainly focussed on niche segments like NDDS platform formulations along with general formulations like modified release dosage forms
+91 96639 19615 / 99728 31500
info@nuwillresearch.com